Margaret A. Hamburg
CIK: 0001266917
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Director
Discretionary Trading P&L
Holdings
About HAMBURG MARGARET A
HAMBURG MARGARET A (SEC CIK 0001266917) files insider reports with the SEC as Director of ALNYLAM PHARMACEUTICALS, INC. (ALNY).
Signal8 holds 2 ownership filings by HAMBURG MARGARET A, all Form 4s, filed between May 12, 2025 and May 22, 2026. Those filings report 2 transactions, from May 8, 2025 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HAMBURG MARGARET A's filings is in CAMBRIDGE, MA.
Recent filings by HAMBURG MARGARET A
Other insiders filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY)
- SUPRAN BRYAN, EVP, CLO and Secretary
- Greenstreet Yvonne, Chief Executive Officer
- PYOTT DAVID E I, Director
- Cravatt Benjamin, Director
- Sigal Charles Elliott, Director
- SCHULMAN AMY W, Director